Researcher Profile Statistics: მოსეშვილი, ირაკლი
Geo Map
Region
#
AS - Asia, other
81
EU - Europe
58
NA - North America
27
Unknown
2
Total
168
Country
#
GE - Georgia
81
SE - Sweden
39
US - United States of America
26
IE - Ireland
11
DE - Germany
4
BE - Belgium
3
CA - Canada
1
MD - Moldova
1
Unknown
2
Total
168
City
#
K'alak'i T'bilisi
64
Dublin
11
Kutaisi
9
Tbilisi
5
Brussels
3
Batumi
2
Frankfurt am Main
2
Atlanta
1
Boardman
1
Chicago
1
other
69
Total
168
Most viewed items
#
ID: 2750 - ფარმაცევტული პროდუქციის სავალდებულო ლიცენზირება
168
Total
168
Most type viewed
#
ID: all -
168
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
168
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2021
0 0
0 0 0 0
0 0 0 0
0 4
4
2022
3 4
6 3 13 6
9 11 9 3
3 8
78
2023
17 8
5 4 4 3
2 3 3 7
2 1
59
2024
3 1
3 10 3 4
3 0 0 0
0 0
27
Ever
168
Geo Map
Region | # |
---|---|
AS - Asia, other | 81 |
EU - Europe | 58 |
NA - North America | 27 |
Unknown | 2 |
Total | 168 |
Country | # |
---|---|
GE - Georgia | 81 |
SE - Sweden | 39 |
US - United States of America | 26 |
IE - Ireland | 11 |
DE - Germany | 4 |
BE - Belgium | 3 |
CA - Canada | 1 |
MD - Moldova | 1 |
Unknown | 2 |
Total | 168 |
City | # |
---|---|
K'alak'i T'bilisi | 64 |
Dublin | 11 |
Kutaisi | 9 |
Tbilisi | 5 |
Brussels | 3 |
Batumi | 2 |
Frankfurt am Main | 2 |
Atlanta | 1 |
Boardman | 1 |
Chicago | 1 |
other | 69 |
Total | 168 |
Most viewed items | # |
---|---|
ID: 2750 - ფარმაცევტული პროდუქციის სავალდებულო ლიცენზირება | 168 |
Total | 168 |
Most type viewed | # |
---|---|
ID: all - | 168 |
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 168 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 |
2022 | 3 | 4 | 6 | 3 | 13 | 6 | 9 | 11 | 9 | 3 | 3 | 8 | 78 |
2023 | 17 | 8 | 5 | 4 | 4 | 3 | 2 | 3 | 3 | 7 | 2 | 1 | 59 |
2024 | 3 | 1 | 3 | 10 | 3 | 4 | 3 | 0 | 0 | 0 | 0 | 0 | 27 |
Ever | 168 |